Randomized Controlled Study Finds Masimo SedLine® Brain Function Monitoring Can Help Guide Anesthesia in Children Undergoing Minor Surgery
Masimo Corporation (MASI)
Last masimo corporation earnings: 4/28 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
masimo.com/about-masimo/investors
Company Research
Source: Business Wire
Anesthesiologists Used Less Sevoflurane to Maintain Appropriate Anesthesia in Children Monitored with Masimo SedLine NEUCHATEL, Switzerland--(BUSINESS WIRE)--Masimo (NASDAQ: MASI) today announced the findings of a randomized, controlled trial published in the Journal of Clinical Anesthesia in which Dr. Melody H.Y. Long and colleagues from the KK Women’s and Children’s Hospital in Singapore evaluated the ability of electroencephalogram (EEG)-guided anesthesia, using Masimo SedLine® brain function monitoring, to reduce the amount of the drug sevoflurane needed to maintain anesthesia in pediatric patients undergoing minor surgery.1 They found that use of SedLine to guide anesthesia reduced sevoflurane requirements and led to a reduced incidence of burst suppression, which has previously been reported to be associated with postoperative delirium.2-7This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220720005607/en/Masimo SedLine
Show less
Read more
Impact Snapshot
Event Time:
MASI
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
MASI alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
MASI alerts
High impacting Masimo Corporation news events
Weekly update
A roundup of the hottest topics
MASI
News
- MASIMO ALERT: Bragar Eagel & Squire, P.C. is Investigating Masimo Corporation on Behalf of Masimo Stockholders and Encourages Investors to Contact the FirmGlobeNewswire
- ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Masimo Corporation Investors to Inquire About Securities Class Action Investigation – MASIGlobeNewswire
- ROSEN, A TOP RANKED LAW FIRM, Encourages Masimo Corporation Investors to Inquire About Securities Class Action Investigation – MASIBusiness Wire
- Masimo Co. (NASDAQ: MASI) had its price target raised by analysts at Piper Sandler from $117.00 to $126.00. They now have a "neutral" rating on the stock.MarketBeat
- Masimo to Present in BofA Securities Health Care ConferenceBusiness Wire
MASI
Earnings
- 5/7/24 - Beat
MASI
Sec Filings
- 5/10/24 - Form DFAN14A
- 5/9/24 - Form SC
- 5/9/24 - Form DEFA14A
- MASI's page on the SEC website